192 related articles for article (PubMed ID: 16918992)
21. [Cost-effectiveness analysis of breast cancer screening with mammography].
Iinuma T
Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
[No Abstract] [Full Text] [Related]
22. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.
Schousboe JT; Sprague BL; Abraham L; O'Meara ES; Onega T; Advani S; Henderson LM; Wernli KJ; Zhang D; Miglioretti DL; Braithwaite D; Kerlikowske K
Ann Intern Med; 2022 Jan; 175(1):11-19. PubMed ID: 34807717
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness analysis of mass screening for breast cancer in Japan.
Okubo I; Glick H; Frumkin H; Eisenberg JM
Cancer; 1991 Apr; 67(8):2021-9. PubMed ID: 1900734
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
25. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
[TBL] [Abstract][Full Text] [Related]
28. [Health economics analysis of breast cancer screening].
Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
[TBL] [Abstract][Full Text] [Related]
29. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
Elixhauser A
Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
[TBL] [Abstract][Full Text] [Related]
30. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
31. Total cost-effectiveness of mammography screening strategies.
Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
[TBL] [Abstract][Full Text] [Related]
32. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
33. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Kerlikowske K; Salzmann P; Phillips KA; Cauley JA; Cummings SR
JAMA; 1999 Dec; 282(22):2156-63. PubMed ID: 10591338
[TBL] [Abstract][Full Text] [Related]
34. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
Griebsch I; Brown J; Boggis C; Dixon A; Dixon M; Easton D; Eeles R; Evans DG; Gilbert FJ; Hawnaur J; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Potterton J; Thompson D; Turnbull LW; Walker LG; Warren R; Leach MO;
Br J Cancer; 2006 Oct; 95(7):801-10. PubMed ID: 17016484
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
37. Economic considerations in breast cancer screening of older women.
Brown ML
J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883
[TBL] [Abstract][Full Text] [Related]
38. Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
Warmerdam PG; de Koning HJ; Boer R; Beemsterboer PM; Dierks ML; Swart E; Robra BP
J Epidemiol Community Health; 1997 Apr; 51(2):180-6. PubMed ID: 9196649
[TBL] [Abstract][Full Text] [Related]
39. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
